125 filings
ARS
2023 FY
BVS
Bioventus Inc - Ordinary Shares
26 Apr 24
Annual report to shareholders
7:43am
DEFA14A
BVS
Bioventus Inc - Ordinary Shares
26 Apr 24
Additional proxy soliciting materials
7:40am
DEF 14A
BVS
Bioventus Inc - Ordinary Shares
Definitive proxy
26 Apr 24
7:38am
PRE 14A
BVS
Bioventus Inc - Ordinary Shares
10 Apr 24
Preliminary proxy
4:08pm
S-8
BVS
Bioventus Inc - Ordinary Shares
20 Mar 24
Registration of securities for employees
4:08pm
8-K
bp7juup7m
12 Mar 24
Bioventus Announces Fourth Quarter and Full Year 2023 Financial Results
7:45am
8-K
0ff689pg0z3e30ol6zqd
19 Jan 24
Entry into a Material Definitive Agreement
8:27am
8-K
yoxhp97vfboglk8p1c
12 Jan 24
Departure of Directors or Certain Officers
5:10pm
S-8
mkfx0l39d26no
9 Jan 24
Registration of securities for employees
8:55am
8-K
pc4o4lnr1dkizoqa2
21 Dec 23
Bioventus Names Robert Claypoole as President and Chief Executive Officer
8:00am
8-K
4k1m5k87gzxna umw
7 Nov 23
Bioventus Reports Third Quarter Financial Results; Raises Full Year 2023 Financial Guidance
7:35am
8-K
hzp3znj2ojh4ht5l
8 Aug 23
Bioventus Reports Second Quarter Financial Results; Introduces Full Year 2023 Financial Guidance
8:02am
S-8
5hcdlpf0wnr
16 Jun 23
Registration of securities for employees
4:56pm
8-K
oly7awl obqsuznzc
9 Jun 23
Departure of Directors or Certain Officers
5:04pm
8-K
7jklqcna 8llcdk
26 May 23
Bioventus Completes Divestiture of its Wound Business
8:39am
8-K
mto 18obb
16 May 23
Bioventus Reports First Quarter Financial Results
4:25pm